-
Intercept, after biotech rollercoaster ride, agrees to buyout by Alfasigma
26 Sep 2023 16:36 GMT
Liver drug developer Intercept Pharmaceuticals has agreed to … Tuesday, ending one of biotechnology’s most noteworthy stories … founder, Alfasigma markets drugs like Zelnorm and rifaximin for irritable … by some trial participants given the drug. Following that …
-
Here’s why we’re not prepared for the next wave of biotech innovation
03 Nov 2022 09:23 GMT
… . The treatment is being developed by two biotechnology companies, Vertex Pharmaceuticals and CRISPR … prove a medicine is truly effective.
The cholesterol drugs known as statins — atorvastatin … trials is so, so difficult.
“My personal thought is that the trial …
-
Innovation Pharmaceuticals Provides Update on Clinical Trials and Revenue Potential of Brilacidin in Inflammatory Bowel Diseases
10 Dec 2019 14:30 GMT
… 2020 to commence clinical trials of Brilacidin for UP… new class of medicine for the treatment of IBD.
As … CerefolinNAC®). Alfasigma recently acquired ZELNORM™ for the American market … pharmaceutical company and the anticipated terms thereof, our future drug …
-
Innovation Pharma Makes Savvy Move in Partnering with Alfasigma for New IBD Drug
24 Jul 2019 23:07 GMT
… in gastrointestinal medications, with 22 drugs and drug candidates inits … Alfasigma USAacquiredthe brand ZELNORM, a prescription pharmaceutical treatment for IBS-C, … , a Phase 2 trial of an oral rinse … order to make the pill (or capsule or tablet …
-
Ironwood Pharmaceuticals' (IRWD) CEO Mark Mallon on Q2 2019 Results - Earnings Call Transcript
31 Jul 2019 01:37 GMT
… President
Mike Shetzline – Chief Medical Officer
Conference Call Participants
David … everyone to the Ironwood Pharmaceuticals Second Quarter 2019 Investor … 2b clinical trial of 7246 for the treatment of pain … prucalopride, as well as Zelnorm. I mean, there…
-
US WorldMeds reintroduces Zelnorm (tegaserod) for treating IBS-C in women under 65
02 Apr 2019 09:04 GMT
Pharmaceutical company US WorldMeds revealed on … Drug Administration (FDA) for the relaunch of its twice-daily oral Zelnorm (tegaserod) treatment … 29 placebo-controlled trials and newly-available sources of treatment outcome data …
-
FDA Approves the Reintroduction of Zelnorm (tegaserod) for Irritable Bowel Syndrome with Constipation (IBS-C) in Women Under 65
03 Apr 2019 07:53 GMT
… Drug Administration (FDA) for the reintroduction of Zelnorm™ (tegaserod), a twice-daily oral treatment … clinical trials, patients taking Zelnorm saw … Zelnorm. Stop taking Zelnorm and get medical … personal approach to pharmaceuticals – pioneering research …
-
Attention Biotech Investors: Mark Your Calendar For These October PDUFA Dates
26 Sep 2018 21:03 GMT
… several clinical trial results announcements and a few FDA approvals triggering moves …
Jazz Knocks FDA Altar For Pediatric Sleep Disorder Drug
Company: Jazz Pharmaceuticals PLC … 's sNDA for Zelnorm for the treatment of women with irritable …
-
Overview and Treatment of IBS With Predominant Constipation in Women
… adequate response, tegaserod (Zelnorm) is a second-line … guidelines also discuss tricyclic antidepressants (TCAs) as another … mainstay of treatment for IBS-C, these medications come with … insert. Boston, MA: Ironwood Pharmaceuticals, Inc; 2021.
14. Trulance …
-
Pliant Therapeutics Announces Appointments of Darren Cline and Thomas McCourt to Board of Directors
08 Mar 2023 21:01 GMT
… biotechnology company focused on discovering and developing novel therapeutics for the treatment … is a seasoned pharmaceutical industry executive … and growth of ZELNORM™. In addition, … FDA) in IPF and PSC and Orphan Drug Designation from the European Medicines …